
A clinician-guided protocol targeting visceral adiposity — the deep abdominal fat that diet, exercise, and even GLP-1s consistently leave behind.
Takes 90 seconds · 100% private · free


















Tesamorelin-based · Daily subcutaneous · Clinician-guided


FSA / HSATakes 90 seconds · 100% private · free
Tesamorelin-based protocol · subcutaneous daily injection · supplies included.
Board-certified clinician review + baseline metabolic labs included.
Month-to-month · cancel anytime · FSA & HSA accepted.
Quick answers
*Price shown applies to the monthly plan. Actual price will depend on plan prescribed. Final treatment fit depends on clinician review.





40% of U.S. adults have clinically significant visceral fat. Most aren't candidates for Wegovy or Zepbound. Most have nowhere to go. This protocol exists for them.
It's the fat that wraps your liver, pancreas, and intestines. Metabolically active. Hormonally disruptive. Far more dangerous than the fat under your skin — and uniquely resistant to diet alone.
The fat layer right under your skin. The kind you can pinch on your arms, thighs, hips. Cosmetically annoying — but metabolically harmless.
Stored deep around your organs. Releases inflammatory hormones into your bloodstream 24/7. Linked to insulin resistance, fatty liver, cardiovascular disease, type 2 diabetes, and metabolic syndrome.
0×
Higher risk of type 2 diabetes with elevated visceral fat
0.4×
Cardiovascular event risk vs. subcutaneous fat at same BMI
~0%
Of U.S. adults have clinically elevated visceral fat — most undiagnosed
Tesamorelin works on your growth-hormone axis, not your appetite — aimed at the deep fat packed around your organs.

Every day
A tiny injection, usually into the belly. Takes seconds — we walk you through the first one.

Weeks 1–4
Tesamorelin is a GHRH analog: it prompts your pituitary to release more of your own growth hormone.

Weeks 4–12
In trials, deep visceral fat fell while the pinchable fat under the skin stayed largely unchanged.

Week 12
Compare your waist and labs with your clinician, then decide next steps.
Typical check-in points, not a guarantee. Individual results vary.
Waist-to-height ratio is a simple screen for central fat. Above 0.5 is a common signal to take a closer look.
Measure your waist at the belly button, relaxed. A screening tool, not a diagnosis. Ashwell M, et al. Obes Rev. 2012.
| Tesamorelin | GLP-1 | |
|---|---|---|
| Primary target | Visceral (deep) fat | Appetite and overall weight |
| How it works | Prompts your own GH release | Reduces hunger, slows digestion |
| Can be used together | Yes | Yes |
| Daily at-home injection | Yes | Weekly |
Your clinician decides whether either or both are appropriate.
Average HealSend member waist circumference and visceral fat metric change over the first 12 weeks of the protocol.

Marcus T., 44
Started protocol after Wegovy stalled
“Lost 28 pounds on Wegovy but the gut wouldn't go. Three months on this and I'm down 2.5 inches in the waist. The mirror finally caught up with the scale.”
42→39.5"
Waist circumference
−18%
Visceral fat (DEXA)
Outcomes the clinical literature and our member data both support. Individual results vary — provider-prescribed when appropriate.
Targeted at visceral fat — not overall weight
Clinician-guided, lab-monitored, and built for the belly GLP-1s leave behind.
Visceral Fat Reduction
Average visceral adipose tissue reduction vs. placebo in the 26-week NEJM phase III trial.
Waist Circumference
Average waist circumference change reported over the 12-week protocol.
Visible Change
Most members see measurable waistline change by week 12, with the largest shift between weeks 8 and 12.
Ongoing Care
Unlimited clinician messaging, baseline labs, and an 8-week recheck included.
Day Promise
No fine print. No retention scripts.
Unlike most peptides being marketed today, the compound used in this protocol is FDA-approved (for HIV-associated lipodystrophy) with multiple large randomized trials specifically measuring visceral fat reduction in adults.
Featured Study
Falutz J, Allas S, Blot K, et al. New England Journal of Medicine. N=412 adults, 26-week double-blind randomized placebo-controlled trial.
−15.4%
visceral adipose (vs. placebo)
−2.0"
avg waist circumference
−50
mg/dL avg triglyceride drop
Reviewed by HealSend Clinical Team



Dr. R. Adler & team
Board-certified metabolic medicine & endocrinology
Complete a quick form and meet with a licensed medical provider 100% online. They'll determine if a personalized treatment plan is right for you.

If eligible, your custom prescription will be shipped directly to your door — fast and free.

We'll be with you every step of the way with regular check-ins and on-demand medical support to keep you on track.

Pharmacy Standards & Safety

3rd-party verified
Zero contaminants
Comfort balanced
Below USP limit


Life-changing results
Takes 90 seconds · 100% Private · Free
Everything we get asked about this protocol. If your question isn't here, message a clinician before you commit.

Always available
7 days a week · 8:00am - 8:00pm ET
Care Team Support
Secure in-app messaging
Email us
yourhealth@healsend.comPatient care line
+1 (888) 282-5851A clinician builds a protocol around your actual visceral fat burden. No guesswork. 90-day money-back guarantee.